These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
292 related items for PubMed ID: 8352069
1. Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats. Lauritzen DB, Balena R, Shea M, Seedor JG, Markatos A, Le HM, Toolan BC, Myers ER, Rodan GA, Hayes WC. J Bone Miner Res; 1993 Jul; 8(7):871-9. PubMed ID: 8352069 [Abstract] [Full Text] [Related]
2. Individual and combined effects of exercise and alendronate on bone mass and strength in ovariectomized rats. Fuchs RK, Shea M, Durski SL, Winters-Stone KM, Widrick J, Snow CM. Bone; 2007 Aug; 41(2):290-6. PubMed ID: 17544352 [Abstract] [Full Text] [Related]
3. Prostaglandin E2 (PGE2) and risedronate was superior to PGE2 alone in maintaining newly added bone in the cortical bone site after withdrawal in older intact rats. Ma YF, Lin BY, Jee WS, Lin CH, Chen YY, Ke HZ, Li XJ. J Bone Miner Res; 1997 Feb; 12(2):267-75. PubMed ID: 9041060 [Abstract] [Full Text] [Related]
4. Effects of 4-amino-1-hydroxybutylidene bisphosphonate on bone biomechanics in rats. Toolan BC, Shea M, Myers ER, Borchers RE, Seedor JG, Quartuccio H, Rodan G, Hayes WC. J Bone Miner Res; 1992 Dec; 7(12):1399-406. PubMed ID: 1481726 [Abstract] [Full Text] [Related]
5. Effects of continuous alendronate treatment on bone mass and mechanical properties in ovariectomized rats: comparison with pamidronate and etidronate in growing rats. Azuma Y, Oue Y, Kanatani H, Ohta T, Kiyoki M, Komoriya K. J Pharmacol Exp Ther; 1998 Jul; 286(1):128-35. PubMed ID: 9655851 [Abstract] [Full Text] [Related]
6. A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats. Ke HZ, Crawford DT, Qi H, Simmons HA, Owen TA, Paralkar VM, Li M, Lu B, Grasser WA, Cameron KO, Lefker BA, DaSilva-Jardine P, Scott DO, Zhang Q, Tian XY, Jee WS, Brown TA, Thompson DD. J Bone Miner Res; 2006 Apr; 21(4):565-75. PubMed ID: 16598377 [Abstract] [Full Text] [Related]
7. Onion decreases the ovariectomy-induced osteopenia in young adult rats. Huang TH, Mühlbauer RC, Tang CH, Chen HI, Chang GL, Huang YW, Lai YT, Lin HS, Yang WT, Yang RS. Bone; 2008 Jun; 42(6):1154-63. PubMed ID: 18387868 [Abstract] [Full Text] [Related]
8. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia. Tanaka M, Mori H, Kayasuga R, Ochi Y, Kawada N, Yamada H, Kishikawa K. Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415 [Abstract] [Full Text] [Related]
9. Intermittent on/off prostaglandin E2 and risedronate are equally anabolic as daily PGE2 alone treatment in cortical bone of ovariectomized rats. Ma YF, Pan Z, Jee WS, Lin CH, Liang HH, Chen H, Pun S, Li XJ. J Bone Miner Res; 1997 Dec; 12(12):2108-12. PubMed ID: 9421244 [Abstract] [Full Text] [Related]
11. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats. Hornby SB, Evans GP, Hornby SL, Pataki A, Glatt M, Green JR. Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877 [Abstract] [Full Text] [Related]
12. Effects of combined treatment with eldecalcitol and alendronate on bone mass, mechanical properties, and bone histomorphometry in ovariectomized rats: a comparison with alfacalcidol and alendronate. Sugimoto M, Futaki N, Harada M, Kaku S. Bone; 2013 Jan; 52(1):181-8. PubMed ID: 23041510 [Abstract] [Full Text] [Related]
13. Effects of the bisphosphonate YM175 on bone mineral density, strength, structure, and turnover in ovariectomized beagles on concomitant dietary calcium restriction. Motoie H, Nakamura T, O'uchi N, Nishikawa H, Kanoh H, Abe T, Kawashima H. J Bone Miner Res; 1995 Jun; 10(6):910-20. PubMed ID: 7572315 [Abstract] [Full Text] [Related]
16. The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. Balena R, Toolan BC, Shea M, Markatos A, Myers ER, Lee SC, Opas EE, Seedor JG, Klein H, Frankenfield D. J Clin Invest; 1993 Dec; 92(6):2577-86. PubMed ID: 8254015 [Abstract] [Full Text] [Related]